Inform, Empower, Connect

Result

Age
Country
City
Trial Status
I am interested in
Trial Phase
Clinicaltrial.gov ID/ NCT Number
Keyword
Trial Name Status Phase Country City
Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma

The main aim of this trial is to assess the effectiveness of thalidomide in combination with interferon alpha for patients with sarcoma including osteosarcoma. All participants in this trial will rece...

Unknown status Phase 2, United States, New York,
Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study

The main aim of this trial is to assess the safety and effectiveness of radiotherapy with Apatinib Mesylate after surgery. The trial is for patients with a range of sarcomas including osteosarcoma. Al...

Unknown status Phase 2, China, Shanghai,
A Study of IMRT in Primary Bone and Soft Tissue Sarcoma

The main aim of the trial was to assess the effectiveness and side effects of intensity modulated radiotherapy (IMRT) in patients with sarcoma. This included osteosarcoma. All patients were allocated ...

Completed Not Applicable, Ireland, United Kingdom, Dublin, Bebington, Belfast, Birmingham, Bristol, Cambridge, Cardiff, Cheltenham, Coventry, Derby, Edinburgh, Exeter, Glasgow, Leeds, Leicester, London, Manchester, Newcastle, Northam...
A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas

The trial aimed to assess the effectiveness of 9-ING-41 in combination with gemcitabine and docetaxel for patientscancer including osteosarcoma that has spread to other places (metastatic) or could no...

Withdrawn Phase 2, United States, Providence,
Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma

This trial aimed to determine the effectiveness of a drug called Sm-EDTMP at treating osteosarcoma that had come back (recurrent), not responded to treatment (refractory), spread from its initial loca...

Completed Phase 2, United States, Baltimore,
MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma

The main aim of this trial is to assess the effectiveness of MASCT-I in combination with PD1 Antibody and Apatinib for patients with sarcoma including osteosarcoma. Participants in this trial will be ...

Recruiting Early Phase 1, China, Shanghai,
Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma

The trial aimed to assess the safety and side effects of a combination of the drugs sorafenib and everolimusfor patient’s osteosarcoma which has returned (relapsed) or has spread to other places (me...

Completed Phase 2, Italy, Candiolo,
Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum

This trial aims to determine whether chemotherapy treatment administered before surgery improves overall survival in patients with nonmetastatic (cancer that has not spread) osteosarcoma of the pelvis...

Recruiting Not Applicable, China, Beijing,
Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective Study

The aim of this study was to assess the effectiveness of different treatments for osteosarcoma that had spread to the lungs (pulmonary metastasis). The trial looked back at data from 127 people with l...

Completed China, Beijing,
Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

The main aim of the trial was to assess the effectiveness and side effects of imatinib mesylate in patients with sarcoma including osteosarcoma. All participants were allocated into groups depending o...

Completed Phase 2, United States, Los Angeles, Washington, Park Ridge, Bethesda, Boston, Ann Arbor, Rochester, New York, Houston,

Disclaimer

  • ONTEX is intended to supplement, not replace, your healthcare team. Patients should always discuss a clinical trial with their healthcare team. If a patient is eligible for a trial the trial team will be able to provide more in-depth information about the trial so the patient can make an informed decision before taking part. Trial information has been sourced from www.clinicaltrials.gov. The content is then reviewed weekly by the Osteosarcoma Now team. All the trials also have a patient-friendly summary and key information section written by the team at Osteosarcoma Now. We have also included a description of the medications being used in the trial and summarised the inclusion and exclusion criteria in the ‘who is this trial (not) for’ sections. To the best of our knowledge the clinical trial database is up-to-date and accurate.However, we cannot assume any liability for the accuracy or completeness of the information.